Dr. Amanda Lewis -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Amanda Lewis, a General Surgery physician based in City, AZ. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Amanda Lewis has received $73,856.98 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Amanda Lewis has received a total of $73,856.98 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $73,856.98 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Amanda Lewis's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Research Funding$73,856.98Clinical trial funding, research grants, and study-related payments

The largest payment category for Dr. Amanda Lewis is Research Funding, accounting for 100% ($73,856.98) of total pharmaceutical payments received. This suggests active involvement in clinical trials and pharmaceutical research programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Amanda Lewis. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Johnson & Johnson$73,856.981

Dr. Amanda Lewis has a financial relationship with Johnson & Johnson, receiving $73,856.98 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Amanda Lewis's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Amanda Lewis has received $73.9K across 1 pharmaceutical payments as a General Surgery physician in City, AZ. Top paying companies include Johnson & Johnson ($73.9K). The physician received a single, substantial payment of $73,857, which is highly concentrated from one company. This payment was designated for research purposes, indicating a potential involvement in clinical trials or studies. The entire payment amount originated from Johnson & Johnson, suggesting a strong, singular relationship with this pharmaceutical company.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Amanda Lewis is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that a single large payment for research does not necessarily indicate bias, but it is one factor to consider alongside the physician's overall practice and patient reviews. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Amanda Lewis Compares to Other General Surgery Physicians

For General Surgery specialists, payment profiles can vary, but a single large research payment from one company is less common than more diversified or smaller, frequent payments.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Amanda Lewis in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Johnson & Johnson$73,856.98researchN/A2025-01-21Not Assessed

Frequently Asked Questions About Dr. Amanda Lewis's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Amanda Lewis received?

Amanda Lewis has received a total of $73.9K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Amanda Lewis taking too much pharma money?

Amanda Lewis has received $73.9K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (General Surgery), the types of payments, and how they compare to peers. The largest payment category is research ($73.9K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Amanda Lewis?

The top pharmaceutical companies paying Amanda Lewis are: Johnson & Johnson ($73.9K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Amanda Lewis receive?

Amanda Lewis's payments by type: research: $73.9K. Research payments indicate involvement in clinical studies.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Amanda Lewis's payments compare to other General Surgery doctors?

To compare, look at the total amount ($73.9K), number of payments (1), and the types of payments received. General Surgery physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Amanda Lewis's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1227823574). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Amanda Lewis's pharma payment profile?

The physician's payment profile is characterized by a single, large transaction, making it difficult to assess broader payment patterns. Amanda Lewis has received $73.9K in total pharma payments.

How does Amanda Lewis compare to peers in General Surgery?

For General Surgery specialists, payment profiles can vary, but a single large research payment from one company is less common than more diversified or smaller, frequent payments.

Are Amanda Lewis's pharma relationships typical for General Surgery?

The high concentration of payment from a single company (100%) warrants further investigation into the nature of the relationship.

What should patients of Amanda Lewis know about these payments?

Consumers should be aware that a single large payment for research does not necessarily indicate bias, but it is one factor to consider alongside the physician's overall practice and patient reviews.

What patterns are visible in Amanda Lewis's payment history?

The payment is solely attributed to research, which is a significant but specific category of pharmaceutical interaction.

Understanding This Doctor Payment Report

This transparency report for Dr. Amanda Lewis is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Amanda Lewis's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Amanda Lewis and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.